In 2023, China's import of syringes stood at 1.2572 billion. From 2024 to 2028, the import values are forecasted to grow steadily from 1.3092 to 1.5168 billion. Year-on-year growth rates between these years indicate consistent increases, reflective of an expanding market need. The compound annual growth rate (CAGR) over this five-year forecast period is approximately 3.7%, suggesting a robust growth trajectory.
Key future trends to watch for include technological advancements in syringe production, changes in healthcare policy in China, and fluctuations in global supply chain dynamics that could impact import volumes.